"Hydroxylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds that contain the (-NH2OH) radical.
| Descriptor ID |
D006898
|
| MeSH Number(s) |
D02.092.570
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydroxylamines".
Below are MeSH descriptors whose meaning is more specific than "Hydroxylamines".
This graph shows the total number of publications written about "Hydroxylamines" by people in this website by year, and whether "Hydroxylamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 4 | 3 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Hydroxylamines" by people in Profiles.
-
Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model. J Infect Dis. 2021 09 01; 224(5):749-753.
-
Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2. Trials. 2021 Aug 23; 22(1):561.
-
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021 09; 28(9):740-746.
-
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19. Curr Opin Virol. 2021 10; 50:17-22.
-
AI-guided discovery of the invariant host response to viral pandemics. EBioMedicine. 2021 Jun; 68:103390.
-
Decoding molnupiravir-induced mutagenesis in SARS-CoV-2. J Biol Chem. 2021 07; 297(1):100867.
-
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nat Commun. 2021 06 03; 12(1):3309.
-
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. J Biol Chem. 2021 07; 297(1):100770.
-
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]. Rev Esp Quimioter. 2021 Oct; 34(5):402-407.
-
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nat Commun. 2021 04 16; 12(1):2295.